{"id":"W1968449590","doi":"10.1016/j.ejca.2011.06.018","title":"Efficacy and safety of bevacizumab in combination with docetaxel for the first-line treatment of elderly patients with locally recurrent or metastatic breast cancer: Results from AVADO","year":2011,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":false,"ca_institutions":"Ottawa Hospital","funders":"Sanofi; F. Hoffmann-La Roche; Amgen","keywords":"Docetaxel; Bevacizumab; Medicine; Metastatic breast cancer; Neutropenia; Internal medicine; Hazard ratio; Febrile neutropenia; Adverse effect; Oncology; Breast cancer; Placebo; Population; Chemotherapy; Cancer; Confidence interval; Surgery; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005434966,0.0003176862,0.00130625,0.0002863502,0.0001954565,0.0005399936,0.000380195,0.0003649863,0.001097247],"category_scores_gemma":[0.0008106731,0.000183217,0.0009571941,0.0002808084,0.0002267161,0.0002707643,0.0001654977,0.001021613,0.0002207562],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006815646,"about_ca_system_score_gemma":0.0005383275,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002671463,"about_ca_topic_score_gemma":0.007889883,"domain_scores_codex":[0.999772,0.00008088234,0.00001466142,0.00004884306,0.00004918044,0.00003442134],"domain_scores_gemma":[0.9996859,0.00007412056,0.00008401908,0.00002479266,0.00003157432,0.00009958206],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4434798,0.02018432,0.04531596,0.001197988,0.003352431,0.0003030237,0.0003625828,0.002103209,0.05121688,0.000219696,0.002687681,0.4295764],"study_design_scores_gemma":[0.223925,0.458552,0.2765048,0.0002690871,0.006960885,0.001619884,0.0004116943,0.002509719,0.01280744,0.0002561061,0.01606897,0.0001143219],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.99184,0.006287486,0.00008492771,0.0001500836,0.00004898766,0.00008503711,0.0004073042,0.0000160703,0.00108004],"genre_scores_gemma":[0.9933817,0.004142378,0.000330172,0.0001856129,0.00007014781,0.00005087525,0.0006245198,0.00001418403,0.00120046],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002671463,"threshold_uncertainty_score":0.005311847,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03946862490249079,"score_gpt":0.3032199038091107,"score_spread":0.2637512789066199,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}